Spanish Ministry of Science · Knowledge Generation Projects 2024

Cancer cells can acquire traits such as rapid growth, immune evasion and drug resistance not only through DNA mutations but also by changing how their genes are expressed. EVOCANCER asks how much of tumour adaptation is heritable and how much is phenotypic plasticity, by reading both layers in the same single cells.

Reference
PID2024-155625NB-I00
Principal investigator
David Posada
Duration
1 September 2025 – 31 August 2029
Host
CINBIO, Universidade de Vigo
Funder
MICIU / AEI
Funding
€375,000

The question

Tumours evolve. As they grow, spread and face treatment, their cells adapt to new environments. That adaptation can come from heritable genetic changes, but also from non-genetic changes in gene expression that let the same genome produce different phenotypes. Disentangling these two routes is key to understanding cancer progression and to anticipating how tumours escape therapy.

What we do

01

Read DNA and RNA in the same cell

We use joint single-cell DNA and RNA sequencing to reconstruct cell lineages and, along them, follow how gene expression changes.

02

Measure the adaptive value of expression changes

We evaluate whether changes in gene expression along cell lineages are adaptive, with a particular focus on phenotypic plasticity, and how they shape tumour progression.

03

Map the tumour microenvironment

Single-cell RNA sequencing (10x Genomics) characterises the cells that surround the tumour and the environments its lineages adapt to.

Cancer models

We focus on colorectal cancer and papillary thyroid cancer, two tumours where lineage history, gene expression and clinical behaviour can be studied together.

Expected impact

Understanding how phenotypic plasticity and heritable change fuel cancer progression should open new ways to improve diagnosis and therapy, in line with the lab’s long-term goal of evolution-informed oncology.

Team

David PosadaPrincipal investigator
João M. AlvesPostdoctoral researcher
Nuria Estévez-GómezPostdoctoral researcher
Kylie ChenPostdoctoral researcher
Alfonso BravoPhD student · FPI fellow funded by this project
Sarai MoledoPhD student
Laura CeidePhD student

Alfonso Bravo holds the 4-year FPI predoctoral contract associated with EVOCANCER, working on the evolution of gene expression along cell lineages in colorectal cancer (see the original call).

Related work from the lab

Ministerio de Ciencia, Innovación y Universidades – Agencia Estatal de Investigación

Project PID2024-155625NB-I00, funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU.